Functional Overexpression of γ-Secretase Reveals Protease-independent Trafficking Functions and a Critical Role of Lipids for Protease Activity*

Presenilins appear to form the active center of γ-secretase but require the presence of the integral membrane proteins nicastrin, anterior pharynx defective 1, and presenilin enhancer 2 for catalytic function. We have simultaneously overexpressed all of these polypeptides, and we demonstrate functional assembly of the enzyme complex, a substantial increase in enzyme activity, and binding of all components to a transition state analogue γ-secretase inhibitor. Co-localization of all components can be observed in the Golgi compartment, and further trafficking of the individual constituents seems to be dependent on functional assembly. Apart from its catalytic function, γ-secretase appears to play a role in the trafficking of the β-amyloid precursor protein, which was changed upon reconstitution of the enzyme but unaffected by pharmacological inhibition. Because the relative molecular mass and stoichiometry of the active enzyme complex remain elusive, we performed size exclusion chromatography of solubilized γ-secretase, which yielded evidence of a tetrameric form of the complex, yet almost completely abolished enzyme activity. γ-Secretase activity was reconstituted upon addition of an independent size exclusion chromatography fraction of lower molecular mass and nonproteinaceous nature, which could be replaced by a brain lipid extract. The same treatment was able to restore enzyme activity after immunoaffinity purification of the γ-secretase complex, demonstrating that lipids play a key role in preserving the catalytic activity of this protease. Furthermore, these data show that it is important to discriminate between intact, inactive γ-secretase complexes and the active form of the enzyme, indicating the care that must be taken in the study of γ-secretase.

[1]  S. Hébert,et al.  Coordinated and widespread expression of γ-secretase in vivo: evidence for size and molecular heterogeneity , 2004, Neurobiology of Disease.

[2]  P. Wong,et al.  Association of γ-Secretase with Lipid Rafts in Post-Golgi and Endosome Membranes* , 2004, Journal of Biological Chemistry.

[3]  C. Haass,et al.  Identification of Distinct γ-Secretase Complexes with Different APH-1 Variants* , 2004, Journal of Biological Chemistry.

[4]  B. de Strooper,et al.  Conserved residues within the putative active site of γ‐secretase differentially influence enzyme activity and inhibitor binding , 2004, Journal of neurochemistry.

[5]  P. S. St George-Hyslop,et al.  The Presenilin Proteins Are Components of Multiple Membrane-bound Complexes That Have Different Biological Activities* , 2004, Journal of Biological Chemistry.

[6]  Rong Wang,et al.  Purification and characterization of the human gamma-secretase complex. , 2004, Biochemistry.

[7]  U. Lendahl,et al.  Pen-2 Is Sequestered in the Endoplasmic Reticulum and Subjected to Ubiquitylation and Proteasome-mediated Degradation in the Absence of Presenilin* , 2004, Journal of Biological Chemistry.

[8]  C. Haass,et al.  Requirement of PEN-2 for Stabilization of the Presenilin N-/C-terminal Fragment Heterodimer within the γ-Secretase Complex* , 2004, Journal of Biological Chemistry.

[9]  D. Selkoe,et al.  Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. , 2004, Biochemistry.

[10]  B. Wolozin,et al.  Cholesterol and the Biology of Alzheimer's Disease , 2004, Neuron.

[11]  D. Selkoe,et al.  Functional γ-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and γ-secretase substrates , 2003, Neurobiology of Disease.

[12]  Y. Ihara,et al.  Gamma-secretase activity is present in rafts but is not cholesterol-dependent. , 2003, Biochemistry.

[13]  A. Goate,et al.  A presenilin dimer at the core of the γ-secretase enzyme: Insights from parallel analysis of Notch 1 and APP proteolysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Selkoe,et al.  Assembly of the γ-Secretase Complex Involves Early Formation of an Intermediate Subcomplex of Aph-1 and Nicastrin* , 2003, Journal of Biological Chemistry.

[15]  Chunjiang Yu,et al.  Regulated hyperaccumulation of presenilin-1 and the "gamma-secretase" complex. Evidence for differential intramembranous processing of transmembrane subatrates. , 2003, The Journal of biological chemistry.

[16]  B. Winblad,et al.  Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain* , 2003, Journal of Biological Chemistry.

[17]  C. Masters,et al.  In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand. , 2003, Biochemistry.

[18]  M. Fortini,et al.  Different cofactor activities in γ-secretase assembly , 2003, The Journal of Cell Biology.

[19]  J. Schmitz,et al.  γ-Secretase Activity Is Associated with a Conformational Change of Nicastrin* , 2003, The Journal of Biological Chemistry.

[20]  Michael S. Wolfe,et al.  γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Regula,et al.  Reconstitution of γ-secretase activity , 2003, Nature Cell Biology.

[22]  B. Strooper,et al.  Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex , 2003, Neuron.

[23]  T. Iwatsubo,et al.  The role of presenilin cofactors in the γ-secretase complex , 2003, Nature.

[24]  Hong Wang,et al.  PEN-2 and APH-1 Coordinately Regulate Proteolytic Processing of Presenilin 1* , 2003, The Journal of Biological Chemistry.

[25]  P. Greengard,et al.  Presenilin-1 Regulates Intracellular Trafficking and Cell Surface Delivery of β-Amyloid Precursor Protein* , 2003, The Journal of Biological Chemistry.

[26]  N. Perrimon,et al.  γ‐Secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  D. Seiffert,et al.  γ-Secretase activity is not involved in presenilin-mediated regulation of β-catenin ☆ , 2002 .

[28]  Hongqiao Li,et al.  Mammalian APH-1 Interacts with Presenilin and Nicastrin and Is Required for Intramembrane Proteolysis of Amyloid-β Precursor Protein and Notch* , 2002, The Journal of Biological Chemistry.

[29]  Harald Steiner,et al.  PEN-2 Is an Integral Component of the γ-Secretase Complex Required for Coordinated Expression of Presenilin and Nicastrin* , 2002, The Journal of Biological Chemistry.

[30]  D. Selkoe,et al.  Complex N-linked Glycosylated Nicastrin Associates with Active γ-Secretase and Undergoes Tight Cellular Regulation* , 2002, The Journal of Biological Chemistry.

[31]  J. Rietdorf,et al.  Presenilin-1 affects trafficking and processing of βAPP and is targeted in a complex with nicastrin to the plasma membrane , 2002, The Journal of cell biology.

[32]  Wei Xu,et al.  aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation , 2002 .

[33]  C. Haass,et al.  A γ‐secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish , 2002, EMBO reports.

[34]  C. Haass,et al.  Presenilin and nicastrin regulate each other and determine amyloid β-peptide production via complex formation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Huaxi Xu,et al.  Presenilin 1 Is Required for Maturation and Cell Surface Accumulation of Nicastrin* , 2002, The Journal of Biological Chemistry.

[36]  S. Younkin,et al.  Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains , 2002, Neurobiology of Disease.

[37]  Valerie A. Hale,et al.  APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Masters,et al.  Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma -secretase inhibitor: implications for presenilin biology. , 2001, The Journal of biological chemistry.

[39]  A. Levey,et al.  Multiple Effects of Aspartate Mutant Presenilin 1 on the Processing and Trafficking of Amyloid Precursor Protein* , 2001, The Journal of Biological Chemistry.

[40]  R. Perlmutter,et al.  Presenilin-dependent γ-secretase activity modulates thymocyte development , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Masters,et al.  Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease. , 2001, Biochemistry.

[42]  Gregory D. Longmore,et al.  γ-Secretase inhibitors repress thymocyte development , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Robert A. Copeland,et al.  Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors* , 2000, The Journal of Biological Chemistry.

[44]  Ruedi Aebersold,et al.  Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing , 2000, Nature.

[45]  Min Xu,et al.  Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.

[46]  Min Xu,et al.  Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Masters,et al.  Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cells. , 2000, Experimental cell research.

[48]  J. Tang,et al.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[50]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[51]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[52]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[53]  D. Selkoe,et al.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.

[54]  C. Masters,et al.  Proteolytic Fragments of Alzheimer’s Disease‐Associated Presenilin 1 Are Present in Synaptic Organelles and Growth Cone Membranes of Rat Brain , 1999, Journal of neurochemistry.

[55]  E. Kojro,et al.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Borchelt,et al.  Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons , 1998, Neuron.

[57]  Joseph D. Buxbaum,et al.  Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor* , 1998, The Journal of Biological Chemistry.

[58]  P. Fraser,et al.  The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-Catenin* , 1998, The Journal of Biological Chemistry.

[59]  D. Selkoe,et al.  The Proteolytic Fragments of the Alzheimer’s Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex* , 1998, The Journal of Biological Chemistry.

[60]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[61]  C. L. Harris,et al.  Evidence That Levels of Presenilins (PS1 and PS2) Are Coordinately Regulated by Competition for Limiting Cellular Factors* , 1997, The Journal of Biological Chemistry.

[62]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.

[63]  D. Borchelt,et al.  Protein Topology of Presenilin 1 , 1996, Neuron.

[64]  D. Borchelt,et al.  Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.

[65]  C. Auffray,et al.  The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. , 1996, Genomics.

[66]  B. Hyman,et al.  Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells , 1996, Nature Medicine.

[67]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[68]  E M Wijsman,et al.  A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.

[69]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[70]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[71]  K. Beyreuther,et al.  Generation of βA4 from the amyloid protein precursor and fragments thereof , 1993 .

[72]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[73]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.

[74]  R. Hynes,et al.  Broad spectrum pan-cadherin antibodies, reactive with the C-terminal 24 amino acid residues of N-cadherin. , 1990, Journal of cell science.

[75]  G. Bloom,et al.  A novel 58-kDa protein associates with the Golgi apparatus and microtubules. , 1989, The Journal of biological chemistry.